Treatment Overview
The Universal Embryo Genetic Panel (UEGP) is a comprehensive preimplantation testing system that screens embryos for a wide range of genetic and chromosomal abnormalities before implantation during IVF. This all-in-one genetic testing platform combines aneuploidy detection (PGT-A), monogenic disorder testing (PGT-M), and structural rearrangement analysis (PGT-SR) into a unified, high-resolution panel.
In Korea, leading fertility centers have pioneered this approach by integrating next-generation sequencing (NGS) with bioinformatics-based embryo profiling to achieve unmatched accuracy and speed in embryo assessment. The Universal Embryo Genetic Panel is designed to detect chromosomal imbalances, inherited genetic mutations, and submicroscopic structural variants — ensuring only the healthiest embryos are selected for transfer.
This technology has positioned Korea as one of the world’s top destinations for advanced reproductive genetics, offering patients precision, safety, and confidence in every IVF cycle.
Purpose & Benefits
The purpose of the Universal Embryo Genetic Panel is to provide a complete and consolidated evaluation of embryo genetics, reducing the risk of transferring embryos with genetic or chromosomal abnormalities.
Key Benefits:
- Comprehensive coverage: Detects chromosomal number errors, inherited single-gene disorders, and balanced/unbalanced translocations in one test.
- Higher implantation and live birth rates: Ensures that only chromosomally normal, genetically healthy embryos are transferred.
- Reduced miscarriage risk: Identifies and excludes embryos with abnormalities responsible for early pregnancy loss.
- Detection of silent genetic carriers: Screens for hidden gene mutations that could cause inherited diseases.
- Supports personalized IVF treatment: Enables customized embryo selection based on the couple’s genetic background.
- Optimized single embryo transfer (SET): Allows transfer of one genetically ideal embryo, minimizing multiple pregnancy risk.
- Enhanced family planning: Provides genetic assurance for future pregnancies and long-term reproductive health.
By combining several layers of testing into one streamlined program, the Universal Embryo Genetic Panel saves time, improves outcomes, and offers unmatched clinical value for patients pursuing IVF in Korea.
Ideal Candidates
The Universal Embryo Genetic Panel is suitable for a broad range of patients, including:
- Women aged 35 years and older seeking to reduce age-related chromosomal abnormalities.
- Couples with a family history of inherited genetic disorders.
- Carriers of single-gene mutations or chromosomal translocations.
- Couples with recurrent miscarriages or repeated IVF failures.
- Patients using donor eggs or sperm who want additional screening assurance.
- Cancer survivors preserving fertility and wishing to ensure future embryo health.
- International patients looking for comprehensive genetic testing and IVF care in a single treatment program.
Korean fertility specialists tailor the use of the Universal Embryo Genetic Panel to each patient’s genetic risk profile and reproductive goals.
Possible Risks & Complications
The Universal Embryo Genetic Panel is safe and minimally invasive but, like any laboratory-based genetic test, involves certain considerations:
- Embryo biopsy risk: Small risk of embryo damage during trophectoderm biopsy, minimized through advanced micromanipulation techniques.
- Complex genetic interpretation: Some results may show mosaicism or variants of uncertain significance, requiring expert review.
- Emotional impact: Couples may face difficult choices if limited embryos meet genetic criteria.
- Financial cost: Combining multiple genetic analyses in one panel adds expense compared to basic screening.
- Extended timelines: Results analysis and embryo cryopreservation may slightly lengthen the IVF cycle.
- Ethical concerns: Deciding which embryos to transfer or store can be emotionally challenging.
Korean fertility centers maintain the highest laboratory standards and offer genetic counseling at every stage to ensure clarity, accuracy, and patient comfort.
Techniques & Laboratory Methods
Korean laboratories use cutting-edge genomic and embryologic methods to deliver the Universal Embryo Genetic Panel with precision and reliability:
1. Trophectoderm Biopsy (Day 5–6 Blastocyst Stage)
Embryos are cultured to the blastocyst stage, and a few cells from the outer layer are gently removed using laser-assisted micromanipulation.
2. Whole-Genome Amplification (WGA)
This process amplifies the DNA extracted from the biopsied cells, ensuring there’s enough material for multiple genetic tests.
3. Next-Generation Sequencing (NGS)
High-resolution sequencing detects chromosomal aneuploidies, microdeletions, duplications, and single-gene disorders simultaneously.
4. Structural Rearrangement Analysis (PGT-SR)
Identifies translocations, inversions, and unbalanced chromosomal structures that may impair embryo viability.
5. Monogenic Disorder Detection (PGT-M)
Screens embryos for known single-gene mutations linked to diseases such as cystic fibrosis, thalassemia, or muscular dystrophy.
6. Integrated Bioinformatics Interpretation
Combines chromosomal, genetic, and structural data to create a holistic embryo profile. AI-assisted ranking systems help prioritize embryos with the best genetic and developmental potential.
7. Vitrification and Secure Cryostorage
Embryos are vitrified (ultra-rapid freezing) while awaiting results and stored under precise, monitored conditions.
The use of multiple genomic technologies within one test makes the Universal Embryo Genetic Panel an efficient and accurate solution for embryo evaluation.
Recovery & Aftercare
Because the Universal Embryo Genetic Panel involves laboratory-based analysis, there is little to no physical recovery needed for patients.
Aftercare Process:
- Post-egg retrieval rest: Mild discomfort and fatigue are normal; recovery takes one to two days.
- Embryo culture and biopsy: Performed in the lab without physical impact on the patient.
- Waiting period: Embryos are cryopreserved while genetic analysis is performed (typically 7–10 days).
- Result review and consultation: Genetic specialists explain results, helping patients select the best embryos for transfer.
- Frozen embryo transfer (FET): Scheduled once a healthy, chromosomally normal embryo is identified.
- Follow-up and monitoring: Ongoing support during and after transfer to ensure hormonal stability and successful implantation.
Korean clinics provide continuous patient engagement and emotional support throughout this process, ensuring comfort and confidence.
Results & Longevity
Korean fertility centers offering the Universal Embryo Genetic Panel consistently report strong clinical outcomes:
- High accuracy: Over 99% precision in identifying chromosomal and single-gene abnormalities.
- Improved implantation rates: Up to 70% success when transferring genetically normal embryos.
- Reduced miscarriage rates: Significant reduction in pregnancy loss compared to non-tested cycles.
- Healthy live births: Greater assurance of normal genetic development in resulting pregnancies.
- Long-term viability: Cryopreserved, genetically screened embryos maintain quality and viability for years.
- Fewer IVF cycles required: Comprehensive screening optimizes embryo selection, improving efficiency.
These results reflect Korea’s commitment to blending advanced genomic science with world-class reproductive care.
Treatment Process in Korea
Step 1 – Initial Consultation & Genetic Assessment
- Review of reproductive and genetic history.
- Genetic counseling to determine panel suitability and specific gene targets if needed.
Step 2 – Ovarian Stimulation & Egg Retrieval
- Controlled ovarian stimulation using tailored hormone protocols.
- Egg retrieval under light sedation.
Step 3 – Fertilization & Embryo Culture
- Fertilization performed using ICSI for precision.
- Embryos cultured to the blastocyst stage in advanced incubator systems.
Step 4 – Trophectoderm Biopsy & Genetic Testing
- Embryos biopsied with micro-laser precision.
- DNA sent for whole-genome sequencing and genetic analysis using the universal panel.
Step 5 – Data Interpretation & Embryo Selection
- AI-driven and expert analysis integrates chromosomal, structural, and single-gene results.
- Euploid, mutation-free embryos identified for transfer.
Step 6 – Frozen Embryo Transfer (FET)
- Selected embryo transferred into the uterus during a hormonally prepared cycle.
Why Korea Excels
- Advanced genomic sequencing and bioinformatics infrastructure.
- Highly skilled embryologists and genetic scientists.
- Integrated PGT platforms combining multiple genetic assessments into one test.
- Fast turnaround time and high accuracy rates.
- Comprehensive international patient support and cost transparency.
Korea’s fertility centers are globally recognized for their innovation and leadership in reproductive genomics.
Cost Range
The cost of the Universal Embryo Genetic Panel in Korea varies depending on the complexity of genetic testing and number of embryos analyzed:
- Universal Embryo Genetic Panel (PGT-A/M/SR): USD 5,000 – 8,000
- Embryo Biopsy & Cryopreservation: USD 1,500 – 2,500
- IVF Cycle (stimulation, retrieval, culture): USD 6,000 – 10,000
- Frozen Embryo Transfer (FET): USD 2,000 – 4,000
- Genetic Counseling & Reporting: USD 300 – 500
- Annual Embryo Storage: USD 300 – 700
A complete IVF + Universal Panel package generally ranges from USD 10,000 to USD 15,000, depending on patient profile and clinic.
Popular Clinics in Korea
- CHA Fertility Center (Seoul / Bundang): Specializes in advanced genomic fertility programs using integrated PGT panels.
- Maria Fertility Hospital: Offers comprehensive embryo genetic screening and personalized IVF services.
- MizMedi Women’s Hospital: Known for precise embryo biopsy and combined genomic testing.
- Hamchoon Women’s Clinic: Focuses on reproductive genetics and chromosomal testing integration.
- Seoul National University Hospital Fertility Center: Combines research innovation with clinical excellence in PGT.
